ECTRIMS 2026 - 42nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis

The ECTRIMS 2026 - 42nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis focuses on advances in multiple sclerosis diagnosis, monitoring, and treatment, examining MRI and biomarker use, pediatric and progressive MS management, immune-targeted therapies, and rehabilitation strategies to improve disease outcomes.

Key Topics

• How and when to obtain brain MRI in the diagnosis and monitoring of multiple sclerosis?
• Update on MAGNIMS guidelines on the use of MRI in the diagnosis and monitoring of multiple sclerosis
• When and how to use gadolinium?
• Value of spinal cord MRI
• How to prevent secondary progression in children with MS
• Paediatric MS
• B cell therapy of MS – pathology, immunology, clinical effects
• Differential diagnosis
• Rehabilitaiton approaches in progressive MS
• Disease modifying treatments in MS
• Neurofilament light chains and other fluid biomarkers in MS
• Bladder and bowel in progressive MS